We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Buccal Swabs Replace Phlebotomy for Postnatal and Pediatric DNA Collection

By LabMedica International staff writers
Posted on 27 Apr 2015
Collection of samples for prenatal and pediatric DNA sequencing procedures is now available via buccal swabs rather than by phlebotomy.

CombiMatrix Corporation (Irvine, CA, USA) a molecular diagnostics company specializing in DNA-based diagnostic services for prenatal, postnatal, and pre-implantation genetic testing has introduced its new Buccal Swab DNA Collection system for the collection of samples to be analyzed with its CombiSNP Array for Pediatric Analysis microarray test.

When using the Buccal Swab system, the patients swabs both cheeks, caps the tube, and then inverts it to mix the DNA with the special preservative solution. More...
Samples are then sent to the CombiMatrix testing laboratory in Irvine (CA, USA), where the DNA is extracted and analyzed on the same test platform as used for blood samples.

"Because of our High Touch service-oriented business model, we are constantly looking for ways to improve our offering to physicians and their patients," said Mark McDonough, president and CEO of CombiMatrix. "The Buccal Swab DNA Collection system is particularly helpful to those physicians who do not have in-house phlebotomy services, and must send their patients to a phlebotomy center. Now, the patient's DNA can be collected in the physician's office without the need for a blood draw. The Buccal Swab DNA Collection system saves patients' time, and offers a painless alternative to a blood draw, which is particularly useful when samples need to be collected from neonatal and pediatric patients. We are excited about offering this option and believe that it will open up new testing avenues for office-based physicians who see patients that require microarray testing. This is largely an untapped market for us until now."

Related Links:

CombiMatrix Corporation



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.